(Q28302597)

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

INTESTINAL (MESENTERIC) VASCULOPATHY II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

7 January 2021

In line for immortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Peroxisome proliferator-activated receptors: nuclear control of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The steroid and thyroid hormone receptor superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Reactive nitrogen and oxygen species in airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Post-ischaemic organ dysfunction: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The role of cytokine-induced neutrophil chemoattractant-1 in neutrophil-mediated remote lung injury after intestinal ischaemia/reperfusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Inflammatory roles of P-selectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The nuclear receptor ligand-binding domain: structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Oxidative stress and reactive nitrogen species generation during renal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

The PPARs: from orphan receptors to drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.10.004

10.1016/J.VPH.2004.10.004

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_6khpexfvjzeghgjavx5suxxd54

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6khpexfvjzeghgjavx5suxxd54

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

15653094

1 reference

Consolidated OpenCitations Corpus – April 2017